0.4051
price up icon1.76%   0.007
 
loading
Schlusskurs vom Vortag:
$0.3981
Offen:
$0.3996
24-Stunden-Volumen:
156.46K
Relative Volume:
0.33
Marktkapitalisierung:
$3.89M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-18.35M
KGV:
-0.3492
EPS:
-1.16
Netto-Cashflow:
$-19.20M
1W Leistung:
+1.68%
1M Leistung:
-1.20%
6M Leistung:
-63.17%
1J Leistung:
-70.64%
1-Tages-Spanne:
Value
$0.3879
$0.4051
1-Wochen-Bereich:
Value
$0.3811
$0.41
52-Wochen-Spanne:
Value
$0.3654
$2.64

Theriva Biologics Inc Stock (TOVX) Company Profile

Name
Firmenname
Theriva Biologics Inc
Name
Telefon
301 417 4364
Name
Adresse
9605 Medical Center Drive, Suite 270, Rockville
Name
Mitarbeiter
21
Name
Twitter
Name
Nächster Verdiensttermin
2024-11-11
Name
Neueste SEC-Einreichungen
Name
TOVX's Discussions on Twitter

Vergleichen Sie TOVX mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
TOVX
Theriva Biologics Inc
0.4051 3.82M 0 -18.35M -19.20M -1.16
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
391.64 101.35B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
456.00 58.66B 2.46B -319.09M -52.09M -2.47
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
562.27 59.43B 14.21B 4.46B 3.56B 39.68
Biotechnology icon
ARGX
Argen X Se Adr
737.56 44.01B 3.06B 1.28B 447.35M 21.30
Biotechnology icon
ONC
Beone Medicines Ltd Adr
340.70 36.56B 3.81B -644.79M -669.77M -6.24

Theriva Biologics Inc Aktie (TOVX) Neueste Nachrichten

pulisher
Sep 30, 2025

How interest rate cuts could boost Theriva Biologics Inc. stockPortfolio Return Report & Entry and Exit Point Strategies - newser.com

Sep 30, 2025
pulisher
Sep 30, 2025

Is Theriva Biologics Inc. (SFY0) stock a defensive play amid uncertaintyAnalyst Upgrade & Scalable Portfolio Growth Methods - newser.com

Sep 30, 2025
pulisher
Sep 30, 2025

Is Theriva Biologics Inc. (SFY0) stock cheap by valuation metrics2025 Sector Review & Safe Entry Zone Tips - newser.com

Sep 30, 2025
pulisher
Sep 30, 2025

What downside risks could hit Theriva Biologics Inc. stockMarket Risk Analysis & Low Volatility Stock Suggestions - newser.com

Sep 30, 2025
pulisher
Sep 30, 2025

Is it time to cut losses on Theriva Biologics Inc.Earnings Overview Summary & Fast Momentum Stock Entry Tips - newser.com

Sep 30, 2025
pulisher
Sep 30, 2025

Will Theriva Biologics Inc. stock remain on Wall Street radarMarket Weekly Review & Daily Entry Point Alerts - newser.com

Sep 30, 2025
pulisher
Sep 29, 2025

How Theriva Biologics Inc. stock performs after earnings2025 Price Momentum & Low Drawdown Momentum Trade Ideas - newser.com

Sep 29, 2025
pulisher
Sep 29, 2025

Published on: 2025-09-29 13:52:37 - newser.com

Sep 29, 2025
pulisher
Sep 29, 2025

Should you hold or exit Theriva Biologics Inc. nowPortfolio Risk Report & Free Technical Pattern Based Buy Signals - newser.com

Sep 29, 2025
pulisher
Sep 29, 2025

Why retail investors favor Theriva Biologics Inc. stockQuarterly Growth Report & Free Safe Capital Growth Stock Tips - newser.com

Sep 29, 2025
pulisher
Sep 29, 2025

Is Theriva Biologics Inc. stock attractive post correctionCPI Data & Community Consensus Stock Picks - newser.com

Sep 29, 2025
pulisher
Sep 29, 2025

Visual analytics tools that track Theriva Biologics Inc. performanceJuly 2025 Decliners & Short-Term Trading Opportunity Alerts - newser.com

Sep 29, 2025
pulisher
Sep 29, 2025

Is this a good reentry point in Theriva Biologics Inc.2025 EndofYear Setup & Low Risk High Reward Ideas - newser.com

Sep 29, 2025
pulisher
Sep 29, 2025

Published on: 2025-09-29 03:59:06 - newser.com

Sep 29, 2025
pulisher
Sep 28, 2025

What analysts say about Theriva Biologics Inc SFY0 stockPrice Action Trading & Low Risk High Yield - earlytimes.in

Sep 28, 2025
pulisher
Sep 28, 2025

What analysts say about Theriva Biologics Inc stockFibonacci Retracement Levels & Machine Learning Stock Picks, Daily - earlytimes.in

Sep 28, 2025
pulisher
Sep 27, 2025

Theriva Biologics Inc Stock Analysis and ForecastInsider Trading Compliance & Small Capital Portfolio - earlytimes.in

Sep 27, 2025

Finanzdaten der Theriva Biologics Inc-Aktie (TOVX)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$20.66
price down icon 2.36%
$84.81
price up icon 1.10%
$30.67
price up icon 4.57%
$98.62
price up icon 0.53%
$144.01
price up icon 1.67%
biotechnology ONC
$340.70
price up icon 2.36%
Kapitalisierung:     |  Volumen (24h):